UnitedHealth Group Incorporated
418.09USD
-6.8900 (-1.62%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on UNH.
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 324.2B | 371.6B | 400.3B | 447.6B | 449.0B | 463.6B |
| Q1 | 80.1B | 91.9B | 99.8B | 109.6B | 111.7B | 113.7B |
| Q2 | 80.3B | 92.9B | 98.9B | 111.6B | 112.0B | — |
| Q3 | 80.9B | 92.4B | 100.8B | 113.2B | — | — |
| Q4 | 82.8B* | 94.4B* | 100.8B* | 113.2B* | 112.3B | — |
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 21.18 | 23.86 | 15.51 | 13.23 | 20.59 | 23.27 |
| Q1 | 5.27 | 5.95 | -1.53 | 6.85 | 6.90 | 8.18 |
| Q2 | 5.34 | 5.82 | 4.54 | 3.74 | 6.04 | — |
| Q3 | 5.55 | 6.24 | 6.51 | 2.59 | — | — |
| Q4 | 5.01* |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
Revenue to net income
| 5.82* |
| 5.97* |
| .011* |
| 2.26 |
| — |
Debt level and coverage